DNA damage responses pathway modulator (Breakpoint Therapeutics)

N/A

Report date: 2025/03/19 11:36:56
NME

Base Information

Drug NameDNA damage responses pathway modulator (Breakpoint Therapeutics)
Drug Alias NameDNA damage reponses pathway modulator (Evotec)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA damage reversal pathway modulatorsDNA replication pathway modulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvotec SE
China Registration ClassN/A

Develop Information

Active CompaniesBreakpoint Therapeutics GmbH
Inactive CompaniesEvotec SE
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A